Stromal gene signatures in large-B-cell lymphomas.


BACKGROUND The addition of rituximab to combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), or R-CHOP, has significantly improved the survival of patients with diffuse large-B-cell lymphoma. Whether gene-expression signatures correlate with survival after treatment of diffuse large-B-cell lymphoma is unclear… (More)
DOI: 10.1056/NEJMoa0802885


5 Figures and Tables

Blog articles referencing this paper